13533-810Level 3
XEMBIFY (immune globulin subcutaneous, human-klhw)
**Product type:** Plasma Derivative
**Active ingredient:** HUMAN IMMUNOGLOBULIN G
**Strength:** 200 mg/mL
**Dosage form:** Solution
**Route:** Subcutaneous
**Labeler:** GRIFOLS USA, LLC
**Marketing category:** BLA (BLA125683)
**Pharmacologic class:** Antigen Neutralization [MoA], Human Immunoglobulin G [EPC], Immunoglobulins [CS], Passively Acquired Immunity [PE]
GET
/api/v1/systems/ndc_fda/nodes/13533-810Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.